$9.03
+0.67%InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
Corporate Secretary
Executive Vice President & Chief Financial Officer
Compensation
$745,297
Executive Vice President & Chief HR Officer
Executive Vice President & Chief Information Officer
President, Chief Executive Officer & Director
Compensation
$772,550
During the last 12 months, insiders have purchased $150K and sold $56K worth of INFU shares, resulting in $95K of net buying activity.
15.0K
131.47K
0
0.00
+131K
+$131K
2.1K
18.91K
0
0.00
+19K
+$19K
0
0.00
0
0.00
+0
+$0
0
0.00
5.8K
55.62K
-56K
-$56K
Steele Barry G
Officer: Executive Vp And Cfo
$80K
Gendron Paul Andrew
Director
$44K
Lachance Carrie
Director, Officer: President And Ceo
$26K
Shuda Scott
Director
$56K
Positive insider sentiment with $95K net buying. Buying activity substantially exceeds selling, indicating insider confidence.
Strong buy/sell ratio. Buying is at least double the selling activity, suggesting robust insider confidence.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
3 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
INFU - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 10, 2026 | April 10, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 10, 2025 | April 10, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 10, 2024 | April 10, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 10, 2023 | April 10, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 04, 2022 | April 04, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 05, 2021 | May 18, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 03, 2020 | May 20, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 05, 2019 | May 15, 2019 | 2019 | |
DEF 14A DEF 14A 2017 N/A | May 22, 2017 | June 22, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | August 01, 2016 | September 07, 2016 | 2016 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.